The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal Carcinoma
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether celecoxib is effective in the treatment of
nasopharyngeal carcinoma by concurrent chemoradiation with weekly nedaplatin.